Phase II
In December 2020, the research program entered a new second phase (2021-2022), thanks to additional support from the Knut and Alice Wallenberg Foundation for, including both the projects funded in 2020 and new studies, in total 101 projects.
The 34 COVID-19 research grants awarded in this second phase, January, 2021, (call 1-3) allow continuation of the projects initiated in phase I, spring 2020, as well as inclusion of new projects and studies on the impact of the different COVID-19 vaccines. Several of the projects funded in 2021 are based on collaboration between PIs previously in the program, while others include new project partners.
Quick link
Program content and structure
The program will have a new structure that will promote collaborations and interactions across the whole program with joint program activities and close link to the SciLifeLab management and SciLifeLab’s infrastructure, including development of the infrastructure resources and capacity for pandemic laboratory preparedness (which SciLifeLab, in December 2020, was commissioned by the Swedish government to establish)
In addition, SciLifeLab Data Centre offers support to the projects in the program with tools and systems, as well as guidance on IT and data management to maximise the impact of the produced data, to promote Open science, and increase FAIRness and data sharing.
Categories and project distribution across categories are presented in the pie charts.
More information
Program activities
A survey was conducted in February 2021 among the first phase program participants, to identify the most valuable activities to focus on and to improve the coordination and support.
Based on the incoming results, the following activities are planned:
- Kick-off meetings for funded projects
- Monthly COVID-19 research seminar series, starting on May 19, continuing in fall 2021
- Individual meetings with Data Centre
- Meetings with SciLifeLab infrastructure
- Public event
Information for Principal Investigators
Funding acknowledgement
Funding through the SciLifeLab and KAW National COVID-19 Research Program, Phase II, call 1-2, should be acknowledged as This study was supported by grants to Science for Life Laboratory from the Knut and Alice Wallenberg Foundation (2020.0241).
Funding through the SciLifeLab and KAW National COVID-19 Research Program, Phase II, call 3 (vaccine projects), should be acknowledged as This study was supported by grants to Science for Life Laboratory from the Knut and Alice Wallenberg Foundation (2020.0299, 2021.0010)
Project financial reporting
Please find below the deadlines for sending the financial reports and requisition regarding KAW-grants for COVID-19 to Isabel Tengkrans, KTH. More information on the requisition process will be sent by email before deadline.
All costs regarding 2021 must be submitted by email by 31st of March 2022.
All costs regarding 2022 must be submitted by email by 31st of March 2023.
Please note that costs that have not been reported by the second, final deadline for this project, cannot be reimbursed.